4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC
View ORCID ProfileGili Regev-Yochay, Tal Gonen, Mayan Gilboa, Michal Mandelboim, Victoria Indenbaum, Sharon Amit, Lilac Meltzer, Keren Asraf, Carmit Cohen, Ronen Fluss, Asaf Biber, Ital Nemet, Limor Kliker, Gili Joseph, Ram Doolman, Ella Mendelson, Laurence S. Freedman, Dror Harats, Yitshak Kreiss, Yaniv Lustig
doi: https://doi.org/10.1101/2022.02.15.22270948
Gili Regev-Yochay
1The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
2Sackler Faculty of Medicine, Tel-Aviv University, Israel
Tal Gonen
1The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
2Sackler Faculty of Medicine, Tel-Aviv University, Israel
Mayan Gilboa
1The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
2Sackler Faculty of Medicine, Tel-Aviv University, Israel
Michal Mandelboim
2Sackler Faculty of Medicine, Tel-Aviv University, Israel
3Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel
Victoria Indenbaum
3Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel
Sharon Amit
4Clinical Microbiology, Sheba Medical Center
Lilac Meltzer
1The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
2Sackler Faculty of Medicine, Tel-Aviv University, Israel
Keren Asraf
5Automated Mega-Laboratory, Laboratory division, Sheba Medical Center
Carmit Cohen
1The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
Ronen Fluss
6Biostatistics and Biomathematics Unit, Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel
Asaf Biber
1The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
2Sackler Faculty of Medicine, Tel-Aviv University, Israel
Ital Nemet
3Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel
Limor Kliker
2Sackler Faculty of Medicine, Tel-Aviv University, Israel
3Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel
Gili Joseph
1The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
Ram Doolman
5Automated Mega-Laboratory, Laboratory division, Sheba Medical Center
Ella Mendelson
2Sackler Faculty of Medicine, Tel-Aviv University, Israel
3Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel
Laurence S. Freedman
6Biostatistics and Biomathematics Unit, Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel
Dror Harats
7The Sheba Medical Center Management, Sheba Medical Center, Tel Hashomer, Israel
Yitshak Kreiss
7The Sheba Medical Center Management, Sheba Medical Center, Tel Hashomer, Israel
Yaniv Lustig
2Sackler Faculty of Medicine, Tel-Aviv University, Israel
3Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel
Data Availability
All data produced in the present study will be available upon reasonable request to the authors
Posted February 15, 2022.
4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC
Gili Regev-Yochay, Tal Gonen, Mayan Gilboa, Michal Mandelboim, Victoria Indenbaum, Sharon Amit, Lilac Meltzer, Keren Asraf, Carmit Cohen, Ronen Fluss, Asaf Biber, Ital Nemet, Limor Kliker, Gili Joseph, Ram Doolman, Ella Mendelson, Laurence S. Freedman, Dror Harats, Yitshak Kreiss, Yaniv Lustig
medRxiv 2022.02.15.22270948; doi: https://doi.org/10.1101/2022.02.15.22270948
4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC
Gili Regev-Yochay, Tal Gonen, Mayan Gilboa, Michal Mandelboim, Victoria Indenbaum, Sharon Amit, Lilac Meltzer, Keren Asraf, Carmit Cohen, Ronen Fluss, Asaf Biber, Ital Nemet, Limor Kliker, Gili Joseph, Ram Doolman, Ella Mendelson, Laurence S. Freedman, Dror Harats, Yitshak Kreiss, Yaniv Lustig
medRxiv 2022.02.15.22270948; doi: https://doi.org/10.1101/2022.02.15.22270948
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (2997)
- Dermatology (256)
- Emergency Medicine (448)
- Epidemiology (12894)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4692)
- Geriatric Medicine (432)
- Health Economics (740)
- Health Informatics (2982)
- Health Policy (1081)
- Hematology (398)
- HIV/AIDS (942)
- Medical Education (439)
- Medical Ethics (116)
- Nephrology (481)
- Neurology (4482)
- Nursing (239)
- Nutrition (656)
- Oncology (2327)
- Ophthalmology (659)
- Orthopedics (262)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1217)
- Primary Care Research (509)
- Public and Global Health (7069)
- Radiology and Imaging (1570)
- Respiratory Medicine (932)
- Rheumatology (454)
- Sports Medicine (390)
- Surgery (496)
- Toxicology (62)
- Transplantation (214)
- Urology (186)